These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 15336592)

  • 1. The biological role of strontium.
    Pors Nielsen S
    Bone; 2004 Sep; 35(3):583-8. PubMed ID: 15336592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strontium ranelate: an increased bone quality leading to vertebral antifracture efficacy at all stages.
    Ortolani S; Vai S
    Bone; 2006 Feb; 38(2 Suppl 1):19-22. PubMed ID: 16455319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Strontium ranelate: a novel concept for the treatment of osteoporosis].
    Dimai HP
    Wien Klin Wochenschr; 2005 Nov; 117(21-22):728-38. PubMed ID: 16416353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation.
    Marie PJ
    Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S11-5. PubMed ID: 16735840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strontium ranelate: a physiological approach for optimizing bone formation and resorption.
    Marie PJ
    Bone; 2006 Feb; 38(2 Suppl 1):S10-4. PubMed ID: 16439191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of long-term treatment with strontium ranelate on bone strontium content.
    Bärenholdt O; Kolthoff N; Nielsen SP
    Bone; 2009 Aug; 45(2):200-6. PubMed ID: 19376283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro.
    Bonnelye E; Chabadel A; Saltel F; Jurdic P
    Bone; 2008 Jan; 42(1):129-38. PubMed ID: 17945546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strontium as therapy for osteoporosis.
    Marie PJ
    Curr Opin Pharmacol; 2005 Dec; 5(6):633-6. PubMed ID: 16183330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Strontium ranelate's (Osseor) dual mode of action: increasing bone mass and decreasing bone resorption].
    Kaliterna DM
    Reumatizam; 2008; 55(2):73-4. PubMed ID: 19024281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strontium-calcium coadministration stimulates bone matrix osteogenic factor expression and new bone formation in a large animal model.
    Li Z; Lu WW; Chiu PK; Lam RW; Xu B; Cheung KM; Leong JC; Luk KD
    J Orthop Res; 2009 Jun; 27(6):758-62. PubMed ID: 19025756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strontium ranelate: the first agent of a new therapeutic class in osteoporosis.
    Neuprez A; Hiligsmann M; Scholtissen S; Bruyere O; Reginster JY
    Adv Ther; 2008 Dec; 25(12):1235-56. PubMed ID: 19066755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No difference between strontium ranelate (SR) and calcium/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trial.
    Anastasilakis AD; Goulis DG; Polyzos SA; Gerou S; Ballaouri I; Efstathiadou Z; Kita M; Avramidis A
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):522-6. PubMed ID: 18625000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strontium administration in young chickens improves bone volume and architecture but does not enhance bone structural and material strength.
    Shahnazari M; Lang DH; Fosmire GJ; Sharkey NA; Mitchell AD; Leach RM
    Calcif Tissue Int; 2007 Mar; 80(3):160-6. PubMed ID: 17340224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in bone strength parameters. The role of strontium ranelate.
    Tournis S
    J Musculoskelet Neuronal Interact; 2007; 7(3):266-7. PubMed ID: 17947810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interfacial behaviour of strontium-containing hydroxyapatite cement with cancellous and cortical bone.
    Ni GX; Lu WW; Xu B; Chiu KY; Yang C; Li ZY; Lam WM; Luk KD
    Biomaterials; 2006 Oct; 27(29):5127-33. PubMed ID: 16781769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet and status at Chalcatzingo: some empirical and technical aspects of strontium analysis.
    Schoeninger MJ
    Am J Phys Anthropol; 1979 Sep; 51(3):295-310. PubMed ID: 394602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bone strontium on BMD measurements.
    Blake GM; Fogelman I
    J Clin Densitom; 2007; 10(1):34-8. PubMed ID: 17289524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new treatment for post-menopausal osteoporosis: strontium ranelate.
    Rizzoli R
    J Endocrinol Invest; 2005; 28(8 Suppl):50-7. PubMed ID: 16323829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The correction of BMD measurements for bone strontium content.
    Blake GM; Fogelman I
    J Clin Densitom; 2007; 10(3):259-65. PubMed ID: 17543560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro effects of strontium ranelate on the extracellular calcium-sensing receptor.
    Coulombe J; Faure H; Robin B; Ruat M
    Biochem Biophys Res Commun; 2004 Oct; 323(4):1184-90. PubMed ID: 15451421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.